Perioperative Intensive Statin Therapy for Neuroprotection in TAVR(PISTNT)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 500 participants.
Also called NCT07087379
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 500 participants
- Sponsor
- Pan Xiangbin
- Registry
-
NCT07087379
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07087379. Randomized; triple masking; primary purpose prevention. Start 2025-10-01 (anticipated); primary completion 2027-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Perioperative Intensive Statin Therapy for Neuroprotection in TAVR(PISTNT)
- Acronym
- PISTNT
- Condition
- Aortic Stenosis
- Condition
- Cerebral Ischaemic Injury
- Intervention (Drug)
- Intensive statin treatment
- Intervention (Drug)
- Placebo Control
- Lead sponsor
- Pan Xiangbin
Record details
- Record id
cardio:ct-nct07087379- Content hash
5cd61ad14b5ba05df0cae076ba7794daf31a89e857d82f1b52bf7b8f050656a7